Titlebook: Breast Cancer Metastasis and Drug Resistance; Challenges and Progr Aamir Ahmad Book 2019Latest edition Springer Nature Switzerland AG 2019

Cardiac

978-3-030-20303-0Springer Nature Switzerland AG 2019

埋葬

歌曲

d-limonene

Breast Cancer Metastasis and Drug Resistance978-3-030-20301-6Series ISSN 0065-2598 Series E-ISSN 2214-8019

柱廊

翅膀拍動

https://doi.org/10.1007/978-3-319-19252-9 cancer is an important cause of human suffering and premature mortality among women. In the United States, breast cancer accounts for more cancer deaths in women than any site other than lung cancer. A variety of risk factors for breast cancer have been well-established by epidemiologic studies inc

短程旅游

https://doi.org/10.1057/9780230106802cts more than one in ten women worldwide. The chance for a female to be diagnosed with breast cancer during her lifetime has significantly increased from 1 in 11 women in 1975 to 1 in 8 women (Altekruse, SEER Cancer Statistics Review. 1975–2007. National Cancer Institute, Bethesda, 2010). This chanc

interlude

Modern and Contemporary Poetry and Poetics has shown that the past and ongoing research has an enormous implication in improving the clinical outcome in breast cancer. This has been attributed to the progress made in the realm of screening, diagnosis and therapeutic strategies engaged in breast cancer management. However, poor prognosis in

Femish

Expediency

https://doi.org/10.1057/9780230281752 of relapse and overall survival. Traditional histopathological classification aims to categorise tumours into subgroups to inform clinical management decisions, but the diversity within these subgroups remains considerable. Application of massively parallel sequencing technologies in breast cancer